223 related articles for article (PubMed ID: 33973154)
1. Subjective cognition and mood in persistent chemotherapy-related cognitive impairment.
Vega JN; Albert KM; Mayer IA; Taylor WD; Newhouse PA
J Cancer Surviv; 2022 Jun; 16(3):614-623. PubMed ID: 33973154
[TBL] [Abstract][Full Text] [Related]
2. Nicotinic treatment of post-chemotherapy subjective cognitive impairment: a pilot study.
Vega JN; Albert KM; Mayer IA; Taylor WD; Newhouse PA
J Cancer Surviv; 2019 Oct; 13(5):673-686. PubMed ID: 31338732
[TBL] [Abstract][Full Text] [Related]
3. Transdermal Nicotine for the Treatment of Mood and Cognitive Symptoms in Nonsmokers With Late-Life Depression.
Gandelman JA; Kang H; Antal A; Albert K; Boyd BD; Conley AC; Newhouse P; Taylor WD
J Clin Psychiatry; 2018 Aug; 79(5):. PubMed ID: 30192444
[TBL] [Abstract][Full Text] [Related]
4. Self-reported chemotherapy-related cognitive impairment compared with cognitive complaints following menopause.
Vega JN; Dumas J; Newhouse PA
Psychooncology; 2018 Sep; 27(9):2198-2205. PubMed ID: 29904964
[TBL] [Abstract][Full Text] [Related]
5. Use of focused computerized cognitive training (Neuroflex) to improve symptoms in women with persistent chemotherapy-related cognitive impairment.
Vega JN; Newhouse PA; Conley AC; Szymkowicz SM; Gong X; Cote S; Mayer I; Taylor WD; Morimoto SS
Digit Health; 2023; 9():20552076231192754. PubMed ID: 37588161
[TBL] [Abstract][Full Text] [Related]
6. Predictors of quality of life among adults with self-reported cancer related cognitive impairment.
Maeir T; Nahum M; Makranz C; Tsabari S; Peretz T; Gilboa Y
Disabil Rehabil; 2023 Mar; 45(6):1056-1062. PubMed ID: 35297702
[TBL] [Abstract][Full Text] [Related]
7. Androgen deprivation therapy and radiation for prostate cancer-cognitive impairment, sleep, symptom burden: a prospective study.
Tulk J; Rash JA; Thoms J; Wassersug R; Gonzalez B; Garland SN
BMJ Support Palliat Care; 2023 Dec; 13(e2):e454-e463. PubMed ID: 34330793
[TBL] [Abstract][Full Text] [Related]
8. Probiotic supplement attenuates chemotherapy-related cognitive impairment in patients with breast cancer: a randomised, double-blind, and placebo-controlled trial.
Juan Z; Chen J; Ding B; Yongping L; Liu K; Wang L; Le Y; Liao Q; Shi J; Huang J; Wu Y; Ma D; Ouyang W; Tong J
Eur J Cancer; 2022 Jan; 161():10-22. PubMed ID: 34896904
[TBL] [Abstract][Full Text] [Related]
9. A systematic review of rehabilitation programs for cognitive impairment related to breast cancer: Different programs at different times?
Merceur M; Reilly KT; Bonan I; Holé J; Hummel E; Cogné M; Jacquin-Courtois S
Ann Phys Rehabil Med; 2024 Jun; 67(5):101832. PubMed ID: 38537525
[TBL] [Abstract][Full Text] [Related]
10. Cognitive Retraining and Functional Treatment (CRAFT) for adults with cancer related cognitive impairment: a preliminary efficacy study.
Maeir T; Makranz C; Peretz T; Odem E; Tsabari S; Nahum M; Gilboa Y
Support Care Cancer; 2023 Feb; 31(3):152. PubMed ID: 36746805
[TBL] [Abstract][Full Text] [Related]
11. Protocol for the Exercise, Cancer and Cognition - The ECCO-Study: A Randomized Controlled Trial of Simultaneous Exercise During Neo-/Adjuvant Chemotherapy in Breast Cancer Patients and Its Effects on Neurocognition.
Kiesl D; Kuzdas-Sallaberger M; Fuchs D; Brunner S; Kommenda R; Tischler C; Hornich H; Akbari K; Kellermair J; Blessberger H; Ocenasek H; Hofmann P; Zimmer P; Vosko MR
Front Neurol; 2022; 13():777808. PubMed ID: 35401389
[TBL] [Abstract][Full Text] [Related]
12. Chemobrain in Breast Cancer: Mechanisms, Clinical Manifestations, and Potential Interventions.
Onzi GR; D'Agustini N; Garcia SC; Guterres SS; Pohlmann PR; Rosa DD; Pohlmann AR
Drug Saf; 2022 Jun; 45(6):601-621. PubMed ID: 35606623
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy-induced cognitive impairment in breast cancer survivors: A systematic review of studies from 2000 to 2021.
Amani O; Mazaheri MA; Moghani MM; Zarani F; Choolabi RH
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1989. PubMed ID: 38351543
[TBL] [Abstract][Full Text] [Related]
14. Associations of plasma brain-derived neurotrophic factor (BDNF) and Val66Met polymorphism (rs6265) with long-term cancer-related cognitive impairment in survivors of breast cancer.
Yap NY; Tan NYT; Tan CJ; Loh KW; Ng RCH; Ho HK; Chan A
Breast Cancer Res Treat; 2020 Oct; 183(3):683-696. PubMed ID: 32696315
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and associated factors of chemotherapy-related cognitive impairment in older breast cancer survivors.
Zhou X; Zhang X; Zhong T; Zhou M; Gao L; Chen L
J Adv Nurs; 2024 Feb; 80(2):484-499. PubMed ID: 37675947
[TBL] [Abstract][Full Text] [Related]
16. Subjective and objective cognitive functioning among patients with breast cancer: effects of chemotherapy and mood symptoms.
Hsu YH; Chen VC; Hsieh CC; Weng YP; Hsu YT; Hsiao HP; Wang WK; Chen HM; Weng JC; Wu SI; Gossop M
Breast Cancer; 2021 Jan; 28(1):236-245. PubMed ID: 33030667
[TBL] [Abstract][Full Text] [Related]
17. Targeting Treatments to Improve Cognitive Function in Mood Disorder: Suggestions From Trials Using Erythropoietin.
Miskowiak KW; Rush AJ; Gerds TA; Vinberg M; Kessing LV
J Clin Psychiatry; 2016 Dec; 77(12):e1639-e1646. PubMed ID: 27835716
[TBL] [Abstract][Full Text] [Related]
18. The distress thermometer predicts subjective, but not objective, cognitive complaints six months after treatment initiation in cancer patients.
Lycke M; Lefebvre T; Pottel L; Pottel H; Ketelaars L; Stellamans K; Eygen KV; Vergauwe P; Werbrouck P; Goethals L; Schofield P; Boterberg T; Debruyne PR
J Psychosoc Oncol; 2017; 35(6):741-757. PubMed ID: 28816636
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Cognition Support Formula® on cognitive function in older adults with subjective cognitive impairment: a protocol for a 26-week, randomised, double-blind, placebo-controlled trial.
Cave AE; Chang DH; Münch GW; Steiner GZ
Trials; 2019 Jun; 20(1):345. PubMed ID: 31182153
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy-related cognitive impairment in older patients with cancer.
Loh KP; Janelsins MC; Mohile SG; Holmes HM; Hsu T; Inouye SK; Karuturi MS; Kimmick GG; Lichtman SM; Magnuson A; Whitehead MI; Wong ML; Ahles TA
J Geriatr Oncol; 2016 Jul; 7(4):270-80. PubMed ID: 27197918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
